These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 15533577

  • 1. Acute elevation of free fatty acids impairs hepatic glucose uptake in conscious rats.
    Nakahara I, Matsuhisa M, Shiba Y, Kuroda A, Nakatani Y, Hatazaki M, Kajimoto Y, Kubota M, Yamasaki Y, Hori M.
    Diabetes Res Clin Pract; 2004 Nov; 66(2):109-18. PubMed ID: 15533577
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
    Boden G, Cheung P, Stein TP, Kresge K, Mozzoli M.
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E12-9. PubMed ID: 12067837
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of free fatty acids on plasma resistin and insulin resistance in awake rats.
    Yang G, Li L, Fang C, Zhang L, Li Q, Tang Y, Boden G.
    Metabolism; 2005 Sep; 54(9):1142-6. PubMed ID: 16125524
    [Abstract] [Full Text] [Related]

  • 6. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta.
    Lam TK, Yoshii H, Haber CA, Bogdanovic E, Lam L, Fantus IG, Giacca A.
    Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E682-91. PubMed ID: 12217885
    [Abstract] [Full Text] [Related]

  • 7. High-fat- and lipid-induced insulin resistance in rats: the comparison of glucose metabolism, plasma resistin and adiponectin levels.
    Li L, Yang G, Li Q, Tang Y, Li K.
    Ann Nutr Metab; 2006 Oct; 50(6):499-505. PubMed ID: 17191023
    [Abstract] [Full Text] [Related]

  • 8. Co-administration of etomoxir and RU-486 mitigates insulin resistance in hepatic and muscular tissues of STZ-induced diabetic rats.
    Bitar MS.
    Horm Metab Res; 2001 Oct; 33(10):577-84. PubMed ID: 11607876
    [Abstract] [Full Text] [Related]

  • 9. Interaction of free fatty acids and epinephrine in regulating hepatic glucose production in conscious dogs.
    Chu CA, Galassetti P, Igawa K, Sindelar DK, Neal DW, Burish M, Cherrington AD.
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E291-301. PubMed ID: 12531743
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I, Jenssen T.
    Scand J Clin Lab Invest; 2005 Feb; 65(4):307-20. PubMed ID: 16076686
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Insulin suppresses PDK-4 expression in skeletal muscle independently of plasma FFA.
    Lee FN, Zhang L, Zheng D, Choi WS, Youn JH.
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E69-74. PubMed ID: 15026305
    [Abstract] [Full Text] [Related]

  • 14. Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux.
    Yoshii H, Lam TK, Gupta N, Goh T, Haber CA, Uchino H, Kim TT, Chong VZ, Shah K, Fantus IG, Mari A, Kawamori R, Giacca A.
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1089-97. PubMed ID: 16390863
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of nonesterified fatty acid availability on tissue-specific glucose utilization in rats in vivo.
    Jenkins AB, Storlien LH, Chisholm DJ, Kraegen EW.
    J Clin Invest; 1988 Jul; 82(1):293-9. PubMed ID: 3292587
    [Abstract] [Full Text] [Related]

  • 17. Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion.
    Moore MC, Cardin S, Edgerton DS, Farmer B, Neal DW, Lautz M, Cherrington AD.
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E226-33. PubMed ID: 14519598
    [Abstract] [Full Text] [Related]

  • 18. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H.
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [Abstract] [Full Text] [Related]

  • 19. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
    Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA.
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
    [Abstract] [Full Text] [Related]

  • 20. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
    Zinker B, Mika A, Nguyen P, Wilcox D, Ohman L, von Geldern TW, Opgenorth T, Jacobson P.
    Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.